← Back to Screener
NeuroOne Medical Technologies Corporation Common Stock (NMTC)
Price$3.44
Value ScoreD
Growth ScoreC
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-25.43%
Price vs S&P 500 (4W)-27.72%
VGM Score38.01
Market Capitalization$29.65M
All Metrics
Book Value / Share (Quarterly)$0.76
P/TBV (Annual)6.32x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)78.70%
Cash Flow / Share (Quarterly)$-0.75
Price vs S&P 500 (YTD)-32.55%
Gross Margin (TTM)54.87%
Net Profit Margin (TTM)-78.34%
EPS (TTM)$-0.62
10-Day Avg Trading Volume0.03M
EPS Excl Extra (TTM)$-0.62
Revenue Growth (5Y)44.35%
EPS (Annual)$-0.54
ROI (Annual)-43.23%
Gross Margin (Annual)67.30%
Net Profit Margin (5Y Avg)-1069.60%
Cash / Share (Quarterly)$0.42
Revenue Growth QoQ (YoY)-53.90%
ROA (Last FY)-33.43%
Revenue Growth TTM (YoY)-0.38%
EBITD / Share (TTM)$-0.53
ROE (5Y Avg)-399.07%
Operating Margin (TTM)-87.71%
Cash Flow / Share (Annual)$-0.35
P/B Ratio4.63x
P/B Ratio (Quarterly)5.97x
Net Income / Employee (Annual)$-200,300
EV / Revenue (TTM)3.09x
Net Interest Coverage (TTM)-21.15x
ROA (TTM)-78.85%
EPS Incl Extra (Annual)$-0.54
Current Ratio (Annual)4.44x
Quick Ratio (Quarterly)4.96x
3-Month Avg Trading Volume0.04M
52-Week Price Return-2.55%
Revenue / Employee (TTM)$484,200
Tangible BV / Share (Quarterly)$0.76
P/S Ratio (Annual)2.45x
Asset Turnover (Annual)1.12x
52-Week High$6.96
Operating Margin (5Y Avg)-1091.47%
EPS Excl Extra (Annual)$-0.54
CapEx CAGR (5Y)-7.39%
Tangible BV CAGR (5Y)29.76%
26-Week Price Return-17.51%
Quick Ratio (Annual)3.41x
13-Week Price Return-31.20%
Total Debt / Equity (Annual)0.18x
Current Ratio (Quarterly)6.41x
Enterprise Value$26.90M
Revenue / Share Growth (5Y)38.39%
Asset Turnover (TTM)1.01x
Book Value / Share Growth (5Y)24.82%
Revenue / Employee (Annual)$672,100
Inventory Turnover (Annual)1.63x
Pretax Margin (Annual)-29.80%
Cash / Share (Annual)$0.79
3-Month Return Std Dev67.68%
Gross Margin (5Y Avg)46.27%
Net Income / Employee (TTM)$-379,400
ROE (Last FY)-50.98%
Net Interest Coverage (Annual)-4.14x
EPS Basic Excl Extra (Annual)$-0.54
P/FCF (TTM)156.07x
Receivables Turnover (TTM)3.47x
Total Debt / Equity (Quarterly)0.13x
EPS Incl Extra (TTM)$-0.62
Receivables Turnover (Annual)16.79x
ROI (TTM)-100.23%
P/S Ratio (TTM)3.40x
Pretax Margin (5Y Avg)-1069.60%
Revenue / Share (Annual)$1.81
Tangible BV / Share (Annual)$0.84
Price vs S&P 500 (52W)-26.92%
Year-to-Date Return-24.40%
5-Day Price Return-7.53%
EPS Normalized (Annual)$-0.54
ROA (5Y Avg)-122.52%
Net Profit Margin (Annual)-29.80%
Month-to-Date Return-3.10%
Cash Flow / Share (TTM)$-0.60
EBITD / Share (Annual)$-0.59
Operating Margin (Annual)-34.94%
LT Debt / Equity (Annual)0.18x
ROI (5Y Avg)-180.98%
LT Debt / Equity (Quarterly)0.13x
EPS Basic Excl Extra (TTM)$-0.62
P/TBV (Quarterly)6.01x
P/B Ratio (Annual)6.28x
Inventory Turnover (TTM)2.19x
Pretax Margin (TTM)-78.34%
Book Value / Share (Annual)$0.85
Price vs S&P 500 (13W)-39.45%
Beta0.56x
Revenue / Share (TTM)$1.04
ROE (TTM)-119.92%
52-Week Low$3.27
vGradeD
gGradeC
mGradeD
vgmGradeD
Show chart for
Earnings Surprise History
Q2 26-0.25est. -0.23
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.25
4.22
4.22
4.22
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
NMTCNeuroOne Medical Technologies Corporation Common Stock | D | C | D | $3.44 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
NeuroOne Medical Technologies develops thin film electrode technology for diagnostic, therapeutic, and monitoring applications in neurology, focusing on epilepsy, Parkinson's disease, and pain management. The company commercializes products including the Evo Cortical, Evo sEEG, and OneRF Ablation System for brain recording, stimulation, and ablation.